Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR44V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,592
Award facts
- Contract value 100% obligated
- $14,592.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $14,592.08 delivery order to Amerisourcebergen Drug Corp on May 26, 2026, for Dupixent 300 mg/2 ml syringes, with ultimate completion on May 27, 2026.
The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX series), which supports pharmaceutical supply across military healthcare systems globally. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FR44V?
SPE2DR26FR44V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 26, 2026.
How much is contract SPE2DR26FR44V worth?
The government has obligated $14,592 on SPE2DR26FR44V.
Is contract SPE2DR26FR44V an order under another contract?
Yes. SPE2DR26FR44V is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR44V competed?
The extent of competition for SPE2DR26FR44V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award